✨ Free AI Report
Reviva Pharmaceuticals Holdings, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Reviva Pharmaceuticals Holdings, Inc.
Research Preview

Reviva Pharmaceuticals Holdings, Inc.: Business Overview, Financials & Competitive Analysis

Reviva Pharmaceuticals is a late-stage pharmaceutical company developing therapies to address unmet medical needs in central nervous system (CNS), inflammatory and cardiometabolic diseases. The company's lead candidat...

Analyst-debate audio for Reviva Pharmaceuticals Holdings, Inc.

AskCyborg analysts argue the bull and bear cases for Reviva Pharmaceuticals Holdings, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Reviva Pharmaceuticals Holdings, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
4/ 10Challenged

Cyborg Score thesis

Preclinical-stage asset in critical regulatory pathway facing near-term financing challenges and delisting...

Read the full analyst-debate transcript →
Industry Clinical-stage CNS therapeutics development
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 22, 2026
AI-Verified Research
30+ Page Report

Get the Latest Reviva Pharmaceuticals Holdings, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Reviva Pharmaceuticals Holdings, Inc. Overview

Pro stress-test →

Reviva Pharmaceuticals is a late-stage pharmaceutical company developing therapies to address unmet medical needs in central nervous system (CNS), inflammatory and cardiometabolic diseases. The company's lead candidate is brilaroxazine, a serotonin-dopamine and neuroinflammatory signaling modulator in development for schizophrenia treatment.

Strategic Profile

Pro stress-test →

Reviva filed a composition-of-matter provisional patent application for a new form of brilaroxazine designed to extend patent life and commercial exclusivity through 2046. Patient enrollment in the RECOVER-2 Phase 3 trial is expected in Q3 2026, with FDA feedback on the new brilaroxazine form expected in mid-2026.

Competitive Landscape

Pro stress-test →

Reviva competes in the antipsychotic/schizophrenia treatment market against established players with approved therapies. Brilaroxazine has demonstrated broad-spectrum efficacy across symptom domains in 790 trial subjects and a generally well-tolerated safety profile in over 900 subjects. Competition comes from both legacy antipsychotics and newer atypical agents.

Industry Context

Reviva Pharmaceuticals Holdings, Inc. operates in Clinical-stage CNS therapeutics development.

Key facts

Founded: 2011 · Headquarters: Cupertino, US · Employees: Unknown · Revenue: $0M (pre-commercial) · Market cap: N/A

What the analysts stress-tested

The top findings that survived the multi-agent debate for Reviva Pharmaceuticals Holdings, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Reviva Pharmaceuticals Holdings, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Abilify (aripiprazole)Widely-used atypical antipsychotic for schizophrenia→Risperdal (risperidone)Established atypical antipsychotic→Latuda (lurasidone)Modern antipsychotic with favorable metabolic profile→

Compare Reviva Pharmaceuticals Holdings, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Reviva Pharmaceuticals Holdings, Inc. operates in Clinical-stage CNS therapeutics development. See how the rest of the sector scores on the Cyborg framework.

Browse Clinical-stage CNS therapeutics development research →
NEW · MCP server

Ask your AI assistant about Reviva Pharmaceuticals Holdings, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Reviva Pharmaceuticals Holdings, Inc. and its top competitor on Cyborg Score”
“What did Reviva Pharmaceuticals Holdings, Inc. do this quarter?”
“Is Reviva Pharmaceuticals Holdings, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Reviva Pharmaceuticals Holdings, Inc. do?+
Reviva Pharmaceuticals is a late-stage pharmaceutical company developing therapies to address unmet medical needs in central nervous system (CNS), inflammatory and cardiometabolic diseases. The company's lead candidat...
What is Reviva Pharmaceuticals Holdings, Inc.'s Cyborg Score?+
Reviva Pharmaceuticals Holdings, Inc. has a Cyborg Score of 4/10 (Challenged). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Reviva Pharmaceuticals Holdings, Inc.'s main competitors?+
Named competitors include Abilify (aripiprazole), Risperdal (risperidone), Latuda (lurasidone). The full competitive landscape is in the AskCyborg report.
How can I get the full Reviva Pharmaceuticals Holdings, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Reviva Pharmaceuticals Holdings, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Reviva Pharmaceuticals Holdings, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9Sezzle Inc.9Carpenter Technology Corporation9Credo Technology Group Holding Ltd9TE Connectivity plc9Rheinmetall AG9Northrop Grumman Corporation9Interactive Brokers Group, Inc.9Berkshire Hathaway Inc.9Mastercard Incorporated8Vera Therapeutics, Inc.8Quoin Pharmaceuticals, Ltd.8Prenetics Global Limited8Strattec Security Corporation8Lesaka Technologies Inc.8Abu Dhabi Ship Building PJSC8Judges Scientific plc8Weathernews Inc.8Orrstown Financial Services, Inc.